Edaravone Dexborneol Treatment Attenuates Neuronal Apoptosis and Improves Neurological Function by Suppressing 4-HNE-Associated Oxidative Stress After Subarachnoid Hemorrhage

Edaravone dexborneol is a novel neuroprotective drug that comprises edaravone and (+)-borneol in a 4:1 ratio. Phase II and III studies have demonstrated that Chinese patients treated with edaravone dexborneol within 48 h of AIS onset have better functional outcomes than those treated with edaravone...

Full description

Saved in:
Bibliographic Details
Main Authors: Qian Chen (Author), Yichen Cai (Author), Xiaoyu Zhu (Author), Jing Wang (Author), Feng Gao (Author), Mingfeng Yang (Author), Leilei Mao (Author), Zongyong Zhang (Author), Baoliang Sun (Author)
Format: Book
Published: Frontiers Media S.A., 2022-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available